Open Citations
Structure-Based Drug Repurposing Through Molecular Docking and ADMET Profiling of FDA-Approved Drugs Targeting SARS-CoV-2 Main Protease (Mpro)
0
Open Citations
Last updated: 2026-10-06 08:58:21
Citing Works
No open citing works have been identified for this article yet.